Bepotastine
RxNorm 863035
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 863035 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: bepotastine.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
INPrescribable
Ingredient (IN):
Bepotastine
(Atom ID: 2991978)
PTPrescribable
Designated preferred name (PT):
Bepotastine
(Atom ID: 6828995)
FNPrescribable
Full form of descriptor (FN):
Bepotastine (substance)
(Atom ID: 6828996)
PTPrescribable
Designated preferred name (PT):
Bepotastine-containing product
(Atom ID: 10797857)
FNPrescribable
Full form of descriptor (FN):
Product containing bepotastine (medicinal product)
(Atom ID: 10810114)
Patient Education
Bepotastine Ophthalmic
Bepotastine ophthalmic is used to treat itching of the eyes caused by allergic conjunctivitis (a condition in which the eyes become itchy, swollen, red, and teary when they are exposed to certain substances in the air). Bepotastine is in a class of medications called antihistamines. It works by blocking the action and preventing the release of histamine, a substance in the body that causes allergic symptoms.
[Learn More]
* Please review the disclaimer below.